HIMS

_hiddenscout

Sick. Yeah I figured the new thing is less like HIMS and just more of a telehealth play to go after things you can't buy over the counter. Like I can see stuff like acne medication being somewhat sticky. Overall market seems happy with the report. Always kind of crazy when you get what is a good year of gains in a day lol. Glad I pulled the trigger like a week or two ago lol.

creemeeseason

Right? Like it's a totally new vertical for them. I've seen comparisons to HIMS, but I'm not really that far yet. This is a specific treatment for acne only. Still, really promising. Also, brand 4 should be launching soon. 1H 2026 I believe.

increase-ban

SOFI, AMD, META, AMZN, PYPL, HOOD, BMNR, AXON, HIMS, NU BMNR is killing me.

aDactyl

I was thinking HIMS

FuckleUp

In honor of the Epstein / 🥭 files being released I bought HIMS calls

_hopkins

HIMS is actually going to end in green!

Impressive_Put_8239

Waiting for HIMS to drop to 20s. Also do we break spy 660 today

RobertFKennedy

Was about to open a position today. Then I decided to submit a lower limit. If market continue to corrects next 1-2 weeks, HIMS will be at $29. I’ll start accumulating then

sanmar2225

The only thing that can save us is TSLA releasing the GLD plated fuckbots powered by NVDA ai chips that automatically inject you with HIMS boner juice while you only live in the META verse and grind up your PLTR social score. Retinas are cloned by scammers so the only way to pay for anything is the sphincter scanner on your HOOD credit account. You still haven’t won the gold bar from premium.

WindMiddle1130

What happened to $HIMS

ADynes

I started last year with $30k and I lost a little over $8k of it. I actually took 10k out so i wouldn't lose more and dumped it into my mortgage. I was emotional, I feared losing, I was impulsive. My biggest issue however was simply not holding even if I believed in a company. I bought like 600 shares of HIMS at $21 and then they had a whole bunch of bad news and I sold at like $17. If I held, or even sold half and held the other half, it ended up recovering up into the 50s and I would have made all my money back plus some. And that's just one example of many in 2024. This year, with the remaining $12k, I started not fretting when something went down if I believed in the company. In general I stopped selling at losses which I understand is easy to say. For the stocks that I had shares on I started selling covered calls at a strike that was above my average cost so if they sold I was still making a profit and if they didn't I was collecting premium. Some sold and i bought back in if the stock dropped. I'm up $6.8k so far this year and I plan on making back the rest before years end. The worst part about this is I also took my kids savings account (making 0.04%) and put that into brokerage account in October of 2023. 60% VOO, 20% VTI, 20% government bonds. In just over 2 years its up 40%. Man I wish I did the same with my money.....

Awkward-Walk-1500

*HIMS

Overt_Dealflow

Anyone else getting ready to hop back into HIMS? I've been waiting for the last week and I'm glad I haven't yet lol

Overt_Dealflow

100k share 1m sell volume on HIMS. This thing is getting hammered

Overt_Dealflow

One of these days I'm finally going to buy back into HIMS. Today is evidently not that day again

Impressive_Put_8239

HIMS is actual garbage lol 38% short interest is nuts

expliciitz

Anyone buying HIMS?

ZombieFrenchKisser

I'm giving SPY some HIMS boner pills, it should take effect by open.

One-Commission-4682

HIMS

lomo82

Question - I have a high yield ETF (HIMY) that obviously is based on HIMS as its underlying. HIMY’s value has nosedived recently - the opposite of how HIMS has behaved. Why do you think that is?

hardcrepe

The Eye of the Penis has seen hell. That is why you should buy calls on HIMS HIMS HIMS.

Gullible_Tae26

Voo, GLD,HIMS,DZP, NBIS, BMNR, MSFT

Impressive_Put_8239

I bought the HIMS dip im ready for it to go flaccid again next week (please go up).

Pleasant_Gold_3634

Calls on HIMS

CEOofBeanz

If NVDA takes HIMS and stays above $190 then ber will be in the stratosphere on Bezo’s Penis Rocket 9000

Wowmuchrya

Buy shares set trailing stop. I’m up 5% on some stuff from open with high beta like HIMS, SOFI, ACHR

budoobudoo

You are probably not wrong. Just not right enough. If we're talking pure alpha in the metabolic disease game, let's zoom east to Hong Kong where the real fireworks are popping off. I'm eyeing Innogen-B (02591.HK) and PegBio (02565.HK) as straight-up superior moonshots right now, all laser-focused on the GLP-1 revolution that's exploding in Asia's massive diabetes and obesity market. These aren't diluted plays like UNH's insurance sprawl or HOOD's trading volatility; they're razor-sharp biotechs riding China's 1.4 billion-person wave, with approvals incoming and valuations that make US counterparts look like overpriced lattes. Let me break down why swapping some of that bag for these HK gems could 5x your portfolio by 2028—pure fire, no fluff. First off, the macro setup in Hong Kong biotech is straight dominance mode. While the US Nasdaq biotech index is grinding up a measly 20% this year, Hong Kong's Hang Seng Biotech Index has ripped 80%+, outrunning even AI hype. Why? Beijing's pumping state cash into "Made in China 2025" for pharma independence, with 14 fresh listings already raising over HK$18 billion in 2025—quadrupling last year's haul—and 36 more queued up. Valuations? HK biotechs trade at 8-10x forward sales on average, versus 18x+ for US peers, giving you dirt-cheap entry into 30%+ CAGR growth as Asia's diabetes epidemic (hello, 140 million cases and counting) meets ultra-long-acting GLP-1s that crush Ozempic's dosing hassle. No DOJ probes or Medicare cuts here—just streamlined NMPA nods and export pipelines to Southeast Asia. HIMS is cute with its telehealth subs, but it's a US middleman facing Amazon's boot; these HK plays own the IP and manufacturing in the world's fastest-scaling market. Take Innogen-B: This beast just exploded 296% on debut in August, opening at HK$72 after pricing at HK$18.68, and it's still humming around HK$50-60 with HK$683 million fresh in the tank from an IPO oversubscribed 5,365 times—HK$370 billion in bids from 260k investors, second-hottest in Hong Kong this year. Their crown jewel, Efsubaglutide Alfa (branded Diabegone), is Asia's first homegrown humanized long-acting GLP-1 agonist, already greenlit for type 2 diabetes in China and barreling through late-stage trials for obesity and MASH (that fatty liver goldmine worth $30 billion globally). Early data? 7% weight drop in four weeks, with monthly dosing that laps weekly shots—perfect for compliance in a market where 80% of patients ghost treatments. They're deploying IPO cash for Phase III global pushes, commercial ramps, and CNS add-ons, turning red ink (losses narrowed to HK$175 million last year) into black by mid-2026. Compared to HIMS' 50x P/E bloat and GLP-1 supply glut risks, Innogen's at <5x sales with zero revenue yet—pure asymmetry. Bears whine about Eli Lilly/Novo competition, but Innogen's local pricing edge (half the cost) and China-first moat mean they snag 10-15% market share easy, printing HK$10 billion revenue by 2030. UNH? It's a sleepy dividend cow at 13x earnings, dodging cyber headaches but capped at 8-10% growth; Innogen's your uncapped rocket to HK$300/share. Then PegBio seals the deal as the stealth assassin. Listed earlier this year at HK$15.60, raising HK$301 million for a HK$6 billion val, it dipped to HK$10 on open but clawed back to HK$15+ on pipeline heat—up 7% monthly despite broader volatility. Their lead, PB-119, is another long-acting GLP-1 banger for diabetes and obesity, with NMPA acceptance last year and marketing greenlight eyed for Q1 2026. Preclinicals on PB-2301 (GLP-1/GIP dual) and PB-2309 (triple agonist) target NASH and rare endocrines, diversifying beyond HIMS' one-trick pony. R&D burn was HK$280 million in 2022, tapering to HK$76 million YTD as trials wrap, with cash at HK$27 million pre-IPO now beefed for launch and expansions. Losses ticked up slightly to HK$283 million last year on zero revenue, but that's biotech math—post-approval, ARPU from chronic scripts hits HK$500/year per patient in a 500 million obese Asian pool. Versus HOOD's cyclical 70% transaction reliance (hello, 35% revenue crater in '22), PegBio's recurring revenue moat is ironclad, with PEGylation tech for custom peptides adding service upside. Analysts are mum on ratings yet, but the sector tailwind screams Buy; at 4x projected sales, it's a steal next to UNH's regulatory quicksand (DOJ antitrust, 85% loss ratios). PegBio could 4x to HK$60 by 2027 if PB-119 captures 5% China share, while HOOD prays for bull markets. Bottom line, apes: HIMS/HOOD/UNH are fine for balanced bags, but Innogen and PegBio are the asymmetric edges—cheaper entries, explosive China growth (20% GDP healthcare slice by 2030), and GLP-1 purity without US baggage. HK's policy rocket fuel means 50-100% pops on approvals alone, while US names grind through comps and comps. I'm allocating 20% here; dips under HK$45 for Innogen and HK$12 for PegBio are no-brainers. DYOR, markets flip fast, but this is where the smart money's flowing east. Who's jumping in? 🚀🇭🇰 #HKBiotech #GLP1Bets

budoobudoo

Yo apes, dropping my two cents on the long-term bull/bear showdown for HIMS, HOOD, and UNH because someone asked for the real tea, not the CNBC fluff. This is 3-5 year horizon stuff, not day-trade noise, so buckle up. Everything here is fresh off Nov 2025 data—earnings, filings, analyst takes, short interest, the works. No copypasta, all reworded in my own voice. Let’s ride. Starting with HIMS, the telehealth rocket that’s up triple digits this year and chilling around forty-five bucks a share. Forward earnings multiple is chunky at 50x, but the growth is stupid: 80%+ revenue pops projected straight through 2027, mostly riding the GLP-1 weight-loss wave plus mental health and women’s health add-ons. They’ve got 1.5 million subscribers now, average revenue per user climbing 20% year-over-year, and EBITDA margins just cracked 15%. Cash flow per share could hit five bucks by 2028 if they keep compounding. Hedge funds are stacking in—38 big players now versus 31 last quarter. Zacks slapped a Strong Buy on it. Bull case says they grab 5% of a hundred-billion-dollar telehealth pie and the stock prints two hundred or higher by decade’s end. The Novo Nordisk breakup? Shorts calling it a disaster, but bulls say it’s a nothing-burger—HIMS just pivots to their own compounded versions and keeps the party going. Flip the script to the bear side and things get spicy. Short interest still north of 15%, gross margins are juicy at 80% but operating costs are ballooning. GLP-1 supply is gonna flood the market by 2027 and crush pricing power; right now 40% of revenue is one category. Amazon Pharmacy and Teladoc are lurking with deeper pockets and real infrastructure. DCF on the dark side spits out twenty bucks a share if growth throttles to 20%. One guy on here already dumped his entire bag calling the moat “non-existent.” DOJ is sniffing around compounding rules, and recessions make people skip the $99/month subscription real quick. Net-net, I’m tilting bullish if you buy dips under forty, but if the weight-loss hype dies, bears feast. Next up, HOOD—the meme broker that turned legit and sits at $130 after a 150% YTD rip. Funded accounts over 25 million and growing 30% year-over-year, average revenue per user north of $150 thanks to crypto trading (20% of revenue), margin loans, and Robinhood Gold subs hitting a million users. They’re sitting on six billion cash, zero debt, and just bought a crypto wallet to keep expanding. Crypto ETFs are soaking up fifty billion in inflows, retail is back in force, and 24/7 trading plus new ETF launches scream “everything app” for millennials and Gen Z. Technicals show a consolidation triangle ready to break; Mizuho’s old fourteen-dollar target got obliterated months ago. Bull case says three hundred to four hundred by 2030 if the risk-on party keeps rolling. Bears, though? Oof. Seventy percent of revenue is still transaction-based, so any bear market and volumes crater—remember 2022 when revenue dropped 35% overnight. RSI is 72, stock’s a hundred percent above its 200-day moving average, classic overbought territory. Schwab and Fidelity are eating lunch with better tools and no payment-for-order-flow drama. SEC fines and regulatory heat never fully go away. If interest rates tank and volatility dries up, monthly active users stall hard. Bear DCF lands around fifty bucks. I’m riding the bull wave in a bull market, but I’ll be adding on any 20% pullback to eighty. Recessions turn HOOD into a pumpkin. Last but not least, UNH—the healthcare behemoth that’s down 20% YTD to $310 after the cyberattack mess and Medicare headwinds. Still a dividend king with a 3% yield and four hundred billion in annual revenue. Optum is the growth engine—projected to two hundred billion by 2028 with AI squeezing costs and margins climbing past 8%. Medicare Advantage enrollment up double digits every year, EPS compounding 12% like clockwork. Post-dip, it’s trading 13x forward earnings versus an 18x historical average. Bull DCF says five hundred easy by 2028 as healthcare eats 20% of GDP. Ten billion annual buybacks and a track record of beating the S&P in ten of the last twelve bear markets. Management says full recovery in three to five years. Bear case is regulatory Armageddon. DOJ is probing Optum acquisitions, Medicare could slice premiums 5%, medical loss ratios are stuck above 85% after the Change Healthcare breach cost them two billion and counting. Claims inflation is real, pricing power is slipping. Bear DCF lands at two hundred flat—35% downside from here. Policy risk under any administration is the wildcard. Still, I’m calling this a screaming value play. Bulls win the long game unless the regulators go full scorched earth. Wrapping it: HIMS and HOOD are your growth moonshots—10%+ CAGR if stars align. UNH is the defensive cash cow that prints in any weather. Spread your bets, watch Q4 earnings for the next leg, and always do your own homework because Wall Street changes its mind faster than a diamond-hand paper-hands. What’s your play, degenerates? 🚀🩳

PercTrader

Fomod into UUUU you’re not alone still holding $HIMS and $MP but kinda bought at the top. These bags are starting to hurt physically 😭

doniker99

Puts on $HIMS? Unless you want him to watchlist penny stocks next

Soulcraver

HIMS can help with that, calls on this guys limp dick!

TheoryInttro

Bad day to be in Google and AMD. Imma need google to have a little talk with HIMS about some medication to get it back up.

milifiliketz

Got me some HIMS, RKLB, ENVX, NBIS and IREN today

MitchCurry

Six months is nothing. No one should care what the *stock price* of a company they own has done over the past 6 months, but rather than should care about the underlying business. But if you want to talk stock price, I'll go back to my original point of being long-term oriented rather than short-term. CROX over the past 10 years is +705%. HIMS is +270% since it went public 5.5 years ago. CELH is +6,900% in the past 10 years.

YesterdayAmbitious49

This process only works if you know what to buy in the first place. 6 months ago CROX was a darling of this sub. Now -40%. Next up was HIMS -40% and of course CELH -30%.

johndsmits

You know 🥭 had a big emergency dinner with bank & hedge fund execs last night. Related? Dang ORCL, biggest gain, biggest drop. Obvious took a pill from HIMS.

No-Pattern-2890

HIMS needs to take some of their own pp pill bc they cant keep it up

TensionOk40

HIMS - buy the dip

ThrowawayAl2018

Ah reality check today, all indexes took a beating and so did HIMS (under $37 at time of writing). You can try DCA but without knowing where the bottom is, best play is to aim for break even. However holding cash during times of uncertainty is better, cutting losses before it becomes a drain in your portfolio. tldr; buy high sell low.

BlooregardQKazoo

But HIMS advertises on podcasts by saying crass words that normal advertisers won't say. That's as good as a moat!

HeftyBox3580

$40 HIMS puts post earnings was easiest play all year. Cancelled all my subscriptions earlier this year since their products don’t work for hair loss/ED when I can get generics that work for 90% of what HIMS was charging me

Cardiologist_Actual

Advice. Down 50% on $HIMS 41c 11/28. Hold or sell

Kaiuai

Novo Nordisk & Eli Lilly will distribute their weight loss drugs via Mangoceuticals / MangoRX, a tiny company with $20million market cap. This on top of the deal with TrumpRx. Makes me wonder if the supposed "ongoing negotation" with Hims & Hers will bear fruit, especially with the 2 companies' history. What do you think about HIMS's chances in the near future? I read that semaglutide (weight loss) forms a huge chunk of their 2024 and 2025 revenue stream. Is semaglutide also their most profitable segment? [https://www.reuters.com/business/healthcare-pharmaceuticals/mangoceuticals-partners-with-lilly-novo-nordisk-sell-weight-loss-drugs-2025-11-13/](https://www.reuters.com/business/healthcare-pharmaceuticals/mangoceuticals-partners-with-lilly-novo-nordisk-sell-weight-loss-drugs-2025-11-13/)

Cardiologist_Actual

$HIMS - what do we think?

SlfImpr

$BBAI, $CCCX, $NBIS, $HIMS, $ELF, $ACHR, $SMR  **+**  BTC, ETH, SOL Some good deals now for ➡️ EOY 2025 and early 2026 run **^(Catalysts)** * ^(Fed stops QT by end of this month) * ^(Federal employee paychecks start re-hydrating the liquidity) * ^(Santa rally) * ^(Rate cut in Dec or Jan)

SlfImpr

$BBAI, $CCCX, $NBIS, $HIMS, $ELF **+** BTC, ETH, SOL Some good deals now for ➡️ EOY 2025 and early 2026 run

Super_Hans69

Im also holding HIMS @43, though a small part of my portfolio and it was really a speculative position. I think that it had good support around 39$ which it may finally lose today. Possibly a good opportunity to profit on the way down with some puts.

SlfImpr

$BBAI, $CCCX, $NBIS, $HIMS, $ELF **+** BTC, ETH, SOL Some good deals now for EOY 2025 and early 2026 run

Sharaku_US

Keep in mind the stuff HIMS sells is more or less discretionary spending. If the economy is great then yeah, people will want boner pills, hair growth pills, and weight loss injections. But when you're laid off or have problems putting food on the table you think that'll sell?

Guilhelin

Still believe CHWY, HIMS, and DNUT will see a 50% increase over the next 5 months.

Aggravating-Elk-7409

It’s got weird fundamentals. A lot of it stemmed from eating LLY’s and NVO’s lunch with generic Oz but if either strike a deal with the US gov there’s no need for HIMS and they lose all their edge and moat

Impressive_Put_8239

HIMS freee falling. Great shares opportunity to start though.

Acceptable_Bed_6033

!banbet HIMS 30 6w

ikasey24

Has HIMS has a single Green Day in the past month?

Asleep_Swordfish8896

At the rate our country going they gonna be selling a whole lot more of HERS pills to hen HIMS. They don’t want HIMS!! The drugs make yall act hella HERS!!!

SlfImpr

A few months ago, people were downvoting me when I posted that I bought 120 shares of AMD at $108 and they were calling it Advanced Money Destroyer. It is now $256. Yesterday, I * bought 100 shares of NBIS. Will buy more if it drops further because this baby will be > 140-150 by next summer * bought 100 shares of HIMS. Will buy more if it drops further because it will be > 55-65 by next summer

SlfImpr

Yep, I bought 120 shares of AMD at $108 a few months ago when people were calling Advanced Money Destroyer. It is now $256. Yesterday, I * bought 100 shares of NBIS. Will buy more if it drops further because this baby will be > 140-150 by next summer * bought 100 shares of HIMS. Will buy more if it drops further because it will be > 55-65 by next summer

Top-Meaning2626

But drop the price and we give you Medicaid and Medicare And protection from compounders, bc if so then HIMS will be transitioning to HERS FOR BER DICK

Awkward-Walk-1500

Wish I never bought HIMS and META

Brave-Reflection40

Any other HIMS bag holders here?

MrMcjibblets1990

HIMS just broke $39.... LOOK OUT BELOW!!!!!

CartographerFlashy28

Why is $HIMS dumping?? Their weight loss drug is half the price of what people will buy on TrumpRX..

TheoryInttro

Dammit, Google, we talked about this. Do you need a referral to HIMS the way you can never keep it up when you've got some gains?

Kaiuai

I've just read this WSJ article (from March 2025) on some telehealth companies (including HIMS) intentionally downplaying potential side effects to encourage more drug purchases. Many of those customers then got really sick due to the side effects. Before investing in HIMS, good to take into account potential class action lawsuits against HIMS. [https://archive.ph/ZDOYM](https://archive.ph/ZDOYM)

dragonvex_

I heard we’re rotating into biotech and Pharma. I’m hearing buy PFE, NVO, VIKING, HIMS? Can you guys confirm

SlfImpr

🤮🤮🤮 Man, you had so many options like NBIS or HIMS or ACHR or crypto (BTC, ETH, SOL) and you did that!!

DayTradingOG

Here is a port for winners: 1. NBIS 2. IREN 3. BMNR 4. GOOGL 5. AMZN 6. AMD 7. SOFI 8. HOOD 9. HIMS 10. RDDT Just send me a nice Christmas card from a tropical location when you print.

Guilhelin

Still believe in HIMS, CHWY, and DNUT over the next 4 months

SkrillieVanillie

Between April and august I nailed it on HIMS UNH CRWV SNOW QBTS for $50k profits on each more or less. I only had 7k on Jan 1 lol…my first 8 bagger was THC in April then my port just kept pumping. Now I have to start all over

SkrillieVanillie

Well if BROS can somehow get back to 60 by the 21st I’ll have 20k available and I just will stick to shit 3-6 months out or stick with SPY QQQ etc if short dated.. I like HIMS for a comeback also PAYC LULU and CRWV

_hopkins

HIMS you stupid stock

ThatFUTGuy

you know it’s gay when $NBIS and $IREN are still dying but $HIMS recovers lol

6edge9lord

HIMS killin me bruh

Impressive_Put_8239

HIMS going limp whenever I see people talk about squeezes its an indicator to grab puts

Brambletail

Try puts on BBAI and calls on CRWV and leaps on NVO. After puts on SNAP and calls on HIMS. I need to inverse myself i am so consistently wrong at the moment

ikasey24

So, HIMS is basically dead forever now, right?

JJdante

HIMS...not cool...

CEO-of-SOXL

Why HIMS?

Avocadonot

My only recent move is STO 45dte CSP on NVO, HIMS, and holding cash to DCA into high beta AI stocks (NVDA and friends) on red days

ThatFUTGuy

$IREN & $HIMS are going to burn my port to the ground

SkrillieVanillie

Between April and august I nailed it on HIMS UNH CRWV SNOW QBTS for 50k profits on each more or less..I only had 7k on Jan 1 lol…my first 8 bagger was THC in April then my port just kept pumping. Now I have to start all over fml

SkrillieVanillie

yeah all the winners became the losers real real fast...UNH CRWV BROS ACHR APLD QBTS HIMS NVO etc etc. I had made 5 figs off each of these from April to Sept and they all unwound in less than a month meh.....

orangeyougladiator

Damn the HIMS and BYND bots out here downvoting everyone hoping their posts about short squeeze take off.

pineapplekiwipen

HIMS looks plain bad after breaking down from its bullish trendline that's what my crayons tell me

One-Commission-4682

HIMS flat today when mag 7 and majority of market is pumping, Third time this year it hits the 40ish support before going towards $65ish-$70ish top of the range it has been trading in since February of this year.

Brave-Reflection40

Let's all band together and short squeeze the hell outta HIMS.

ThatFUTGuy

what’s with all the HIMS posts all of a sudden?

ThatFUTGuy

sat in HIMS too, bought a nice amount today when 24hr market opened but hasn’t performed huge yet

compvlsions

HIMS is a JUICY play

One-Commission-4682

HIMS getting ready to 🚀🚀🚀 to the moon, highly shorted

Brave-Reflection40

I would make more money just selling puts off SPY every week than trying sell puts on these fucking stocks (AMZN, HIMS, TSM, HOOD). Every week has a major red day that causes me to be a bagholder. Now I have to get rid of them but they never move.

makeammends

He should look into HIMS

Relevant-Welder7407

o we at least see $ 45? What a lovely hsmmer close . $HIMS - https://x.com/kholov23/status/1987940906704535734?s=46

BullyMog

Eating the cum biscuit on XYZ calls (down 75%) and HIMS calls (down 50%). Both dated Jan 2026. Any hope for this retard ?

running_to_empty

Someone, quick, give SPY some HIMS. Dude is going limp fast.

ThatFUTGuy

what’s with $HIMS & $IREN basically having the exact same graphs wtf

ThatFUTGuy

only just realised $HIMS and $IREN are falling like dead weight, $PLTR carrying too much to notice

FabulousCucumber3697

I started small — around $3K initially, then gradually added a few thousand more over time. Total capital now is still under $10K. I mainly run covered calls and cash-secured puts on stocks I actually want to hold long term (TSLL, HOOD, pltr,SOFI, HIMS, APLD, NB, etc.). Pltr hood give a big help!! The goal is to collect theta and IV premium week after week, not chase big moves. It’s been surprisingly consistent — steady income, manageable risk, and compounding works over time.

ThatFUTGuy

imagine somebody was really regarded and hit wall street for every regarded speculative stock and “ai bubble” stock they have, that’s my port right now ($IREN, $PLTR, $BULL, $PATH, $OPEN, $HIMS etc) ALL in my port right now mocking me

RealSchon

HIMS calls to 50 by end of month. Yw